On Thursday, the Supreme Court handed the Trump administration another significant victory in its attempts to defund NIH-sponsored research. In a 5-4 decision, the justices paused the June 16 order of ...

An investigation of the epidemiology and clinical characteristics of neuropathic pain in the UK Biobank has led to the ...

Researchers at the Massachusetts Institute of Technology have developed a generative AI model that was able to generate novel antibiotic structures from either chemical fragments or de novo, starting ...

In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as a prophylactic therapy in the rare and genetic disease hereditary angioedema ...

A group of stakeholders including medical device makers have penned a letter to Centers for Medicare & Medicaid Services administrator Mehmet Oz to urge the agency to cover breakthrough medical ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the formation of an invasive and proliferative ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

Calcific aortic valve disease (CAVD) is the most prevalent acquired valve heart disorder in aging populations. Its most ...

Despite the success of traditional viral-based CAR T-cell therapies against several blood malignancies, their efficacy ...

No matter what level of tariff the Trump administration ends up imposing on biopharmaceuticals across the world, drugs and ...

Jazz Pharmaceuticals plc and Saniona AB have entered into a global license agreement for Jazz to obtain exclusive worldwide ...

Novocure GmbH said it submitted a premarket approval application to the U.S. FDA for its Optune Lua wearable device tumor treating fields therapy for the treatment of locally advanced pancreatic ...